Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Hu Kaijun

Hu Kaijun

Hu Kaijun (#1481)

Global Rank #1481
Country Rank #166
Country China

Hu Kaijun is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 3 B
  • Pharmaceuticals
  • China
  • M
  • 64 Years

Snapshot

Quick Facts

Global Rank #1,481
Country Rank #166
Net Worth $2.8B
Previous Worth $2.8B
Worth Change +$0.0B
Country China
Industry Pharmaceuticals
Age 64 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 13 Sep 2026, 12:00 AM
Residence Beijing, China
World Billionaires List China Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 64
Source Of Wealth Pharmaceuticals, Self Made
Residence Beijing, China
Citizenship China
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $2.8B
Current Net Worth $2.8B

Worth as of May 4, 2026

About Me

Hu Kaijun is chairman and CEO of China Grand Enterprises, an investment company with interests in healthcare, real estate, agriculture and financial services. China Grand is the parent of three publicly-traded companies: Grand Pharmaceutical, Huadong Medicine (a wholesaler) and Grand Industrial Holding (a trading business). Grand Pharmaceutical agreed to buy 87.5% of U.S.-based vascular drug maker BlackSwan Vascular for $37.5 million in 2023. Hu also wholly owns Beijing Yuanda Huachuang Investment, where he also serves as chairman and CEO. Hu's wealth is derived primarily from Grand China's stakes in Huadong Medicine and Grand Pharmaceutical.

Wealth Growth

Net Worth Growth Over Time

Tracking Hu Kaijun's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $2.8B (May 4, 2026)

© Iconic Billionaires